Abstract
Methicillin Resistant Staphylococcus Aureus (MRSA) is a leading cause of hospital acquired infection (HAI) and healthcare-associated pneumonia (HCAP), resulting in increased length of stay, morbidity, cost, and death. Oncology patients' risk for MRSA associated death is upwards of 12% and 43.2% for a 60-day and 6-month period, respectively.
Notes
This material was presented at a hybrid (in-person and virtual) related but nonsynchronous event. This item record may contain a mix of attached files and video embeds. If this item record contains an mp4 file and embedded video, it may not contain a poster or slide deck file. The opposite situation also applies.
Author names appear in alphabetical order within an item record. Priority order and primary presenter information is available in the the attached Abstract file.
Sigma Membership
Pi at-Large
Lead Author Affiliation
University of Maryland, Baltimore, Baltimore, Maryland, USA
Type
Poster
Format Type
Text-based Document
Study Design/Type
Quality Improvement
Research Approach
Translational Research/Evidence-based Practice
Keywords:
Hospital Acquired Infection, Oncology Patients, Methicillin Resistant Staphylococcus Aureus
Recommended Citation
Ejiofor-Okoli, Joan U.; Gourley, Bridgitte; and Murray, Jean, "Improving the rate of admission MRSA screening and intervention" (2023). Creating Healthy Work Environments (CHWE). 74.
https://www.sigmarepository.org/chwe/2022/posters_2022/74
Conference Name
Creating Healthy Work Environments 2022
Conference Host
Sigma Theta Tau International
Conference Location
Washington, DC, USA
Conference Year
2022
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Review Type
Abstract Review Only: Reviewed by Event Host
Acquisition
Proxy-submission
Date of Issue
2023-08-04
Improving the rate of admission MRSA screening and intervention
Washington, DC, USA
Methicillin Resistant Staphylococcus Aureus (MRSA) is a leading cause of hospital acquired infection (HAI) and healthcare-associated pneumonia (HCAP), resulting in increased length of stay, morbidity, cost, and death. Oncology patients' risk for MRSA associated death is upwards of 12% and 43.2% for a 60-day and 6-month period, respectively.